Cited by 152Genetics and Neurodevelopmental DisordersNeuroscience of respiration and sleepHereditary Neurological Disorders

A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits and Improves Respiratory Function in a Mouse Model of Rett Syndrome

Open access
Schmid, Danielle A., Yang, Tao, Ogier, Michael, Adams, Ian, Mirakhur, Yatin, Wang, Qifang, Massa, Stephen M., Longo, Frank M. +1 more·2012·The Journal of Neuroscience

Abstract

Rett syndrome (RTT) results from loss-of-function mutations in the gene encoding the methyl-CpG-binding protein 2 (MeCP2) and is characterized by abnormal motor, respiratory and autonomic control, cognitive impairment, autistic-like behaviors and increased risk of seizures. RTT patients and Mecp2 -null mice exhibit reduced expression of brain-derived neurotrophic factor (BDNF), which has been linked in mice to increased respiratory frequency, a hallmark of RTT. The present study was undertaken to test the hypotheses that BDNF deficits in Mecp2 mutants are associated with reduced activation of the BDNF receptor, TrkB, and that pharmacologic activation of TrkB would improve respiratory function. We characterized BDNF protein expression, TrkB activation and respiration in heterozygous female Mecp2 mutant mice (Het), a model that recapitulates the somatic mosaicism for mutant MECP2 found in typical RTT patients, and evaluated the ability of a small molecule TrkB agonist, LM22A-4, to ameliorate biochemical and functional abnormalities in these animals. We found that Het mice exhibit (1) reduced BDNF expression and TrkB activation in the medulla and pons and (2) breathing dysfunction, characterized by increased frequency due to periods of tachypnea, and increased apneas, as in RTT patients. Treatment of Het mice with LM22A-4 for 4 weeks rescued wild-type levels of TrkB phosphorylation in the medulla and pons and restored wild-type breathing frequency. These data provide new insight into the role of BDNF signaling deficits in the pathophysiology of RTT and highlight TrkB as a possible therapeutic target in this disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0865-11.2012

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schmid, D. A., Yang, T., Ogier, M., Adams, I., Mirakhur, Y., Wang, Q., Massa, S. M., Longo, F. M., & Katz, D. M.
Affiliations
  • Case Western Reserve University (US)
  • Stanford Medicine (US)
  • San Francisco VA Medical Center (US)
Venue
The Journal of Neuroscience
Published
2012-02-01
Volume
32
Issue
5
Pages
1803-1810
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2043690181
Cited by
152
References
41
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 9 · 2016: 14 · 2015: 11 · 2014: 18 · 2013: 20 · 2012: 12
FWCI
11.72
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • Koret Foundation
  • International Rett Syndrome Foundation
  • Office of Research and Development
  • Jean Perkins Foundation
  • National Institute of Neurological Disorders and Stroke (R01NS057398)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
Rett syndrome, TrkB receptor, BDNF signaling, MeCP2, respiratory dysfunction, tachypnea, apnea, medulla, passive optical networks, therapeutic target
MeSH terms
Animals, Benzamides, Disease Models, Animal, Female, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Phosphorylation, Rett Syndrome, Respiratory Mechanics, Mice, Knockout, Receptor, trkB, Mice, Methyl-CpG-Binding Protein 2, Drug Partial Agonism, Mice, 129 Strain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review